Follow The Filings

VRTX Vertex Pharmaceuticals

Vertex Pharmaceuticals earnings company data as of 4:45 AM ET 10/31

  • 1 of 1 EPS beats

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 2 Nov EPS 0.38 — —
Rev $3.43B — —
FY2026 Q2 3 Aug EPS 4.15 4.31 Beat +3.9%
Rev — — —

Insider trades

Open-market buys and sales by VRTX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All VRTX insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $158M sold by 13 insiders under 10b5-1 plans
  1. Ourania Tatsis EVP, Chief Reg. & Quality Off.
    Planned sale
    $787K 1,500 shares at $524.99 3.2% of stake
    Traded Jul 2 Filed Jul 7
  2. Duncan McKechnie EVP, Chief Commercial Officer
    Planned sale
    $800K 1,541 shares at $519.00 12% of stake
    Traded Jul 2 Filed Jul 7
  3. Joy Liu EVP and Chief Legal Officer
    Planned sale
    $416K 828 shares at $502.71 4.1% of stake
    Traded Jul 1 Filed Jul 6
  4. Carmen Bozic EVP and CMO
    Planned sale
    $288K 596 shares at $482.50 3.7% of stake
    Traded Jun 26 Filed Jun 30
  5. Carmen Bozic EVP and CMO
    Planned sale
    $471K 1,020 shares at $462.17 6% of stake
    Traded Jun 18 Filed Jun 23
  6. Carmen Bozic EVP and CMO
    Planned sale
    $1.8M 4,062 shares at $450.00 19% of stake
    Traded Jun 15 Filed Jun 17
  7. Carmen Bozic EVP and CMO
    Planned sale
    $785K 1,745 shares at $450.00 7.7% of stake
    Traded Jun 5 Filed Jun 9
  8. Joy Liu EVP and Chief Legal Officer
    Planned sale
    $364K 828 shares at $439.91 4% of stake
    Traded Jun 1 Filed Jun 3
  9. Carmen Bozic EVP and CMO
    Planned sale
    $888K 1,974 shares at $450.00 8% of stake
    Traded May 29 Filed Jun 2
  10. Mark E. Bunnage EVP, Chief Scientific Officer
    Planned sale
    $15K 33 shares at $453.45 0.5% of stake
    Traded May 15 Filed May 19
  11. Carmen Bozic EVP and CMO
    Planned sale
    $614K 1,354 shares at $453.45 5.2% of stake
    Traded May 15 Filed May 19
  12. Carmen Bozic EVP and CMO
    Planned sale
    $3.1M 6,988 shares at $450.00 21% of stake
    Traded May 12 Filed May 14
  13. Joy Liu EVP and Chief Legal Officer
    Planned sale
    $469K 1,104 shares at $425.02 5.1% of stake
    Traded May 1 Filed May 5
  14. Sangeeta N. Bhatia Director
    Planned sale
    $135K 318 shares at $423.73 6.1% of stake
    Traded May 4 Filed May 5
  15. Joy Liu EVP and Chief Legal Officer
    Planned sale
    $439K 978 shares at $449.17 4.3% of stake
    Traded Apr 1 Filed Apr 3

Also filed in the last 12 months, not counted as buying or selling: 42 stock grants, 42 share withholdings for taxes, 8 option exercises, 4 sales back to the company, and 2 gifts.

SEC filings

Recent issuer filings from EDGAR, 8 shown.

Filed Form Detail Links
8-K 5.02
8-K 5.02
10-Q
8-K 2.02,9.01
8-K 1.01,7.01,8.01,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 5.02,5.07

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.